Trokendi XR® (topiramate) – New indication
April 5, 2017 – Supernus announced the FDA approval of Trokendi XR (topiramate) extended-release capsules, for the prophylaxis of migraine headache in adults and adolescents 12 years of age and older.
Download PDF
